International Clinical Trial: Phase I Clinical Trial Comparing the Pharmacokinetics, Safety and Immunogenicity of Injection SJ04 vs. Eze(R) in Healthy Chinese Female Subjects

Geneva, Aug. 17 -- International Clinical Trials Registry received information related to the study (ChiCTR2600129661) titled 'Phase I Clinical Trial Comparing the Pharmacokinetics, Safety and Immunogenicity of Injection SJ04 vs. Eze(R) in Healthy Chinese Female Subjects' on Aug. 7.

Study Type: Interventional study

Study Design: Cross-over

Primary Sponsor: Suzhou Municipal Hospital

Condition: None

Intervention: T-R group:In the first cycle, SJ04 injection (T) is given, and after a 14-day washout period, the second cycle gives Aize? (R).

Recruitment Status: Not Recruiting

Phase: 1

Date of First Enrollment: 2024-08-12

Target Sample Size: T-R group:24;R-T group:24;

Countries of Recruitment: China

To know more, visit https:/...